We are live on ! Find out more
PALI icon

Palisade Bio

7 hedge funds and large institutions have $38.8M invested in Palisade Bio in 2015 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

28% more call options, than puts

Call options by funds: $723K | Put options by funds: $567K

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0% less ownership

Funds ownership: 0%0% (-0%)

13% less funds holding

Funds holding: 87 (-1)

31% less capital invested

Capital invested by funds: $56.2M → $38.8M (-$17.4M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
7
Holders Change
-1
Holders Change %
-12.5%
% of All Funds
0.19%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
Increased
Reduced
Closed
1
Calls
$723K
Puts
$567K
Net Calls
+$156K
Net Calls Change
+$496K

PALI Hedge Fund Activity: Q1 2015 in Review

7 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Palisade Bio (PALI) for Q1 2015, worth a combined $38.8M — down 31% from $56.2M a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of PALI and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was Fred Alger Management, exiting entirely with an estimated $3.71M sold.

  • 7 institutional investors held Palisade Bio (PALI) as of Q1 2015, down from 8 in Q4 2014.
  • Funds reported $38.8M of Palisade Bio stock for Q1 2015, down 31% quarter-over-quarter.
  • 0 funds opened new Palisade Bio positions in Q1 2015 and 1 closed out, a net change of -1 holder.
  • The largest Palisade Bio seller in Q1 2015 was Fred Alger Management, an estimated $3.71M sold.

Based on aggregated 13F filings for Q1 2015.